Beyond tumour suppression: cGAS-STING pathway in urologic malignancies: Context-dependent duality and therapeutic...

Area of Science:

• Oncology
• Immunology
• Molecular Biology

Background:

• The cGAS-STING pathway exhibits context-dependent tumor-suppressive and pro-tumorigenic activities in urologic malignancies.
• Pathway activation can trigger anti-tumor immunity (IFN transcription, CD8+ T cell infiltration) but also promote cancer development (prostate cancer) or immune escape (renal cell carcinoma).
• The STING/SLC14A1 axis contributes to chemoresistance in bladder cancer.

Purpose of the Study:

• To provide the first systematic comparison of tissue-specific STING regulation in urological malignancies.
• To challenge the traditional tumor suppressor-centric view of the STING pathway.
• To highlight innovative strategies for leveraging STING pathway duality in urologic cancers.

Main Methods:

• Systematic review and comparison of STING pathway regulation across different urologic tumor types.
• Analysis of STING pathway's dual functions in tumor suppression and promotion.
• Identification of therapeutic strategies targeting the STING pathway.

Main Results:

• The duality of cGAS-STING signaling in urologic tumors is confirmed, showing context-dependent effects.
• Targeting the STING pathway, especially in combination with immunotherapies and gene therapies, enhances anti-tumor responses.
• Sex hormone differences in urological malignancies are correlated with cGAS-STING pathway activity.

Conclusions:

• A framework is introduced to harness the dual functions of the cGAS-STING pathway for improved immunotherapy and clinical outcomes.
• Targeting the STING pathway offers a promising strategy to overcome treatment resistance and enhance efficacy in urologic cancers.
• Further research is needed to address the long-term safety and effectiveness of targeted STING treatments.